A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Recruiting · NCT07571200 · Registry updated 2026-09-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS) | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Recruiting | Phase 1 | 2026-09-22 | NCT07571200 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Eli Lilly and Company | 370 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Heritage Medical Research Clinic | Calgary | Canada | 5 |
| Hospital Universitari de Bellvitge | L'Hospitalet de Llobregat | Spain | 24 |
| Hospital Universitari i Politecnic La Fe | Valencia | Spain | 93 |
| McGill University Health Centre | Montreal | Canada | 9 |
| Sunnybrook Research Institute | Toronto | Canada | 13 |
| Universitaetsklinikum Ulm | Ulm | Germany | 34 |
| Universitair Medisch Centrum Utrecht | Utrecht | Netherlands | 49 |
| University Hospital - London Health Sciences Centre | London | Canada | 4 |
| Universitätsklinikum Schleswig-Holstein | Lübeck | Germany | 18 |
| Universitätsmedizin Rostock | Rostock | Germany | 3 |
| UZ Leuven | Leuven | Belgium | 236 |